You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
You need to be a full subscriber to access this feature of the Switzer Super Report. Click here to upgrade your subscription or read recently answered questions below
James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian.
His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007...View more >
Our return to normalcy will be a path fraught with the odd stumble, but that doesn’t mean there’s no value in the share market. Here are 4 stocks returning to levels that imply plenty of value.
A number of ASX-listed companies in the Australian biotech scene are weighing-in to the fight against COVID-19. Here are 10 of the most promising companies battling the virus.
The S&P/ASX All Technology index has rebounded quicker than the broader market. Tech investors are popularly advised to go global and invest in ETFs, but that isn’t completely necessary if you want ..
COVID-19 has hit every industry, which means many stocks are in ‘measured-in-cents' territory that don’t belong there. Here are 4 stocks that will likely rebound and are currently at bargain price..
One word that describes what happened to the oil market in April is: scary! But here are 5 Australian energy stocks that show some investment attractiveness at the moment, as well as 2 junior producer..
Here are 3 inverse ETFs that did give the performance in a crash that they had promised.
